Superior efficacy of tumor cell vaccines grown in physiologic oxygen
about
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsVaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Effects of oxygen on the antigenic landscape of prostate cancer cells.Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoringIncreasing the efficacy of tumor cell vaccines by enhancing cross primingVaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma modelMonomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.Dendritic cells in cancer immunotherapy clinical trials: are we making progress?Vaccine-based immunotherapeutic approaches to gliomas and beyond.Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasTumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.Oxygen is a master regulator of the immunogenicity of primary human glioma cells.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma.
P2860
Q27012618-07CBE2A7-E4D7-4589-92F8-E318251E425BQ33606132-DC68E3BC-5A71-4F6C-99E1-21168D0C3325Q34976095-596BD8E6-E5F7-463D-80A4-FE56D52DB670Q35799695-E227B8EA-AF24-4C9E-AD4B-130CE9144C90Q35845496-091FE804-F2CF-46EE-90C2-2E5000AB161FQ36048767-9671807F-C9E8-454D-949A-CBF352A7CD22Q36288105-1B342397-FA94-4F27-8D7A-20E86B667436Q36514324-52400116-08DA-44A2-A72D-221E8C6E0C4EQ36584178-732E4B37-6BE1-483F-AD45-BB0FA2D6BE06Q37389096-9EF0A93E-67F7-482D-B101-23EED730A093Q38789860-1285372B-D093-44B5-9270-E3CFC554D7F7Q38925761-F082B274-8AF6-4157-9255-DB070CAD6C35Q39316966-F991C644-C600-402C-AFE4-12ABF8D0D52DQ39532047-9415A34A-0BF6-4839-8320-4F6BBDB368F2Q42177993-D0655BC3-98FC-4286-9892-57F8371A0FC4Q42639856-51F5F96E-B706-4E83-AD82-E673FC3576EBQ44600407-16F2B5DC-C3D6-44C5-AF9E-2BA3CBB2B69BQ48622942-C965D1E5-BE68-4673-A3DB-0DAA0C17CDBD
P2860
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@ast
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@en
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@nl
type
label
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@ast
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@en
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@nl
prefLabel
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@ast
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@en
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@nl
P2093
P2860
P1476
Superior efficacy of tumor cell vaccines grown in physiologic oxygen
@en
P2093
Brian M Andersen
Charlie Seiler
Colleen L Forster
David M Zellmer
Flavia E Popescu
John R Ohlfest
Karen S SantaCruz
Michael R Olin
Patrick T Grogan
P2860
P304
P356
10.1158/1078-0432.CCR-10-1572
P407
P577
2010-09-21T00:00:00Z